You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 19, 2024

Patent: 9,877,971

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 9,877,971

Title:	Soft lozenges comprising corticosteroids
Abstract:	Described herein are oral pharmaceutical compositions suitable for chewing, sucking, or buccal dissolution comprising non-systemic corticosteroid soft lozenges, methods for making the same, and methods for treating subjects in need thereof with such lozenges. In particular, the oral composition provides topical, non-systemic administration of one or more active pharmaceutical ingredients to the oral cavity and upper gastrointestinal track, including the esophagus. In one embodiment, the oral pharmaceutical compositions comprise chewable, suckable, or buccally-dissolvable soft lozenges for the treatment of esophageal lesions. The soft lozenges provide topical, non-systemic delivery of corticosteroids to the esophagus and oral cavity.
Inventor(s):	Zhao; Yinyan (Greensboro, NC), Hughey; Justin (Asheboro, NC), Vaughn; Jason (Browns Summit, NC), Fang; Qi (Oak Ridge, NC)
Assignee:	Banner Life Sciences LLC (High Point, NC)
Application Number:	15/181,462
Patent Claims:	see list of patent claims

Details for Patent 9,877,971

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Janssen Biotech, Inc.	REMICADE	infliximab	For Injection	103772	08/24/1998	⤷ Try a Trial	2035-06-15
Genentech, Inc.	XOLAIR	omalizumab	For Injection	103976	06/20/2003	⤷ Try a Trial	2035-06-15
Genentech, Inc.	XOLAIR	omalizumab	Injection	103976	09/28/2018	⤷ Try a Trial	2035-06-15
Glaxosmithkline Llc	NUCALA	mepolizumab	For Injection	125526	11/04/2015	⤷ Try a Trial	2035-06-15
Glaxosmithkline Llc	NUCALA	mepolizumab	Injection	125526	06/06/2019	⤷ Try a Trial	2035-06-15
Glaxosmithkline Llc	NUCALA	mepolizumab	Injection	125526	01/22/2022	⤷ Try a Trial	2035-06-15
Teva Respiratory, Llc	CINQAIR	reslizumab	Injection	761033	03/23/2016	⤷ Try a Trial	2035-06-15
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.